Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

64 results
Display

Long non-coding RNA linc00152 acting as a promising oncogene in cancer progression

Seo D, Kim D, Kim W

The incidence and mortality rate of cancer continues to gradually increase, although considerable research effort has been directed at elucidating the molecular mechanisms underlying biomarkers responsible for tumorigenesis. Accumulated evidence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer

Zhou J, Chen WR, Yang LC, Wang J, Sun JY, Zhang WW, He ZY, Wu SG

PURPOSE: The study aimed to search and identify genes that were differentially expressed in breast cancer, and their roles in cancer growth and progression. MATERIALS AND METHODS: The Gene Expression Omnibus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer

Yi HS, Chang JY, Kim KS, Shong M

Thyroid cancer is one of the most common malignancies of endocrine organs, and its incidence rate has increased steadily over the past several decades. Most differentiated thyroid tumors derived from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pheochromocytoma Developed in a Boy with Multiple Endocrine Neoplasia Type 2A Confirmed by the RET Proto-Oncogene Mutation

Park SY, Jin MJ, Choi EM, Kang SJ, Choi JH, Shim YJ, Kim HS, Jung EY, Lee HJ, Choi MS, Kim HW

A 9-year-old boy presented with increased sweating and abdominal pain. His mother and uncle had been diagnosed with bilateral pheochromocytoma and medullary thyroid carcinoma. Magnetic resonance imaging of the boy's...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of the RET Oncogene Germline Mutations in Korean Medullary Thyroid Carcinoma: A Literature Review

Sin DJ, Min JW, Chang MC

PURPOSE: Germline mutation of the RET oncogene results in multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid cancer (FMTC). We reviewed the literature to determine the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medullary Thyroid Carcinoma: 25-year Experience and the Results of the RET Proto-oncogene Screening Test

Jeong JJ, Lee YS, Kang SW, Sung TY, Lee SC, Nam KH, Chang HS, Chung WY, Park CS

PURPOSE: Medullary thyroid carcinoma (MTC) is a rare thyroid tumor and its clinical course is quite variable. The aim of this study was to retrospectively analyze our clinical and laboratory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Family of Multiple Endocrine Neoplasia Type 2A with a C634R Mutation and a G691S Polymorphism in RET Proto-oncogene

Yun SW, Yoo WS, Hong KH, Kim BH, Kang MH, Choo YK, Park HY, Kim DH, Chung HK, Chang MC, Kwon MS, Kim HJ

Multiple endocrine neoplasia type 2A (MEN2A) is an autosomal dominant syndrome characterized by the presence of a medullary thyroid carcinoma, pheochromocytoma and hyperparathyroidism. MEN2A arises due to germline missense mutations...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Amplification of the HER-2/neu Oncogene and Topoisomerase II-alpha by Chromogenic in Situ Hybridization in Breast Cancer

Kim HS, Kim BG, Cha SJ, Lee TJ, Park SJ, Lim HM, Park SI

  • KMID: 1521593
  • J Korean Surg Soc.
  • 2007 Aug;73(2):87-95.
PURPOSE: HER-2/neu is the most frequently amplified oncogene in breast cancer. Topoisomerase II-alpha is a key enzyme in DNA replication and it is a molecular target for many anti-cancer drugs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
CD56+ T-cell Prolymphocytic Leukemia Showing a High Expression Level of TCL1 Oncogene: A Case Report with a Review of the Literature

Yun HK, Shin MG, Kim HJ, Kim HR, Park JY, Cho D, Kee SJ, Kim YH, Shin JH, Suh SP, Ryang DW

T-cell prolymphocytic leukemia (T-PLL) is a rare mature post-thymic T-cell malignancy with infiltration to the blood, bone marrow, lymph node, liver, spleen and skin; this disease has a poor prognosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Multiple Endocrine Neoplasia Type 2B early Diagnosis by RET Proto-oncogene Analysis and Prophylactic Total Thyroidectomy

Kim BS, Rhie YJ, Koh H, Kim DH, Choi SH

  • KMID: 1510419
  • J Korean Soc Pediatr Endocrinol.
  • 2006 Jun;11(1):104-109.
Multiple endocrine neoplasia type 2B (MEN 2B) is a rare autosomal-dominant hereditary syndrome which includes medullary thyroid carcinoma (MTC), pheochoromocytoma, multiple ganglioneuromas, gastrointestinal disorders and marfanoid face. MTC is the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A family of multiple endocrine neoplasia type 2A associated with a C618R mutation in RET proto-oncogene

Kim NH, Kim JH, Nam JH, Park JP, Park JE, Choi YS, Park YH

  • KMID: 1833332
  • Korean J Med.
  • 2006 Apr;70(4):448-454.
Medullary thyroid carcinoma (MTC) is a relatively rare malignant thyroid disease that accounts for approximately 1% to 5% of all thyroid carcinomas. MTC occurs as a sporadic disease and as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation of C-erbB-2 Oncogene Amplification by Chromogenic in situ Hybridization and Expressions of Cell Cycle Regulatory Proteins in Infiltrating Duct Carcinoma of the Breast

Park BK, Kim BG, Cha SJ, Park SJ, Lim HM, Park SI, Lee TJ

  • KMID: 2210285
  • J Korean Surg Soc.
  • 2006 Jan;70(1):14-24.
PURPOSE: Gene amplification and/or over-expression of the c-erbB-2 are linked with poor prognosis in breast cancer. There has been only a few reports about the connection of c-erbB-2 oncogene amplification...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Familial Medullary Thyroid Carcinoma with a E768D Mutation in RET Proto-Oncogene

Kim YK, Kim JW, Ahn SM, Song KE, Jung SH, Kim DJ, Chung YS, Lee KW, Kim CH, Hong JH, Jeong SY, Kim HJ

A medullary thyroid carcinoma, a neoplasm of parafollicular C cell origin, occurs as a sporadic or hereditary disease. A hereditary medullary thyroid carcinoma is an autosomal dominantly inherited disease, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Double Minutes Containing C-MYC oncogene with a Normal Karyotype in Acute Myelogenous Leukemia: A Case Report

Kim HS, Cho HC, Moon Y, Nahm CH, Choi JW, Yi SG, Kim SH

  • KMID: 2082793
  • Korean J Lab Med.
  • 2005 Jun;25(3):152-154.
We report a case of a female karyotype that was normal except for double minutes (dmin) in acute myeloid leukemia. Using fluorescence in situ hybridization, the amplification of C-MYC was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of HER-2/neu Oncogene in Korean Women with Early-onset Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization

Choi DH, Lee MH, Ahn YH, Lee DW, Shin DB, Carter D, King BL, Haffty BG

  • KMID: 2329036
  • J Korean Breast Cancer Soc.
  • 2003 Dec;6(4):255-262.
PURPOSE: The purpose of this work was to investigate the prognostic significance of of HER-2/neu (HER-2) oncogene protein overexpression in Korean women with early-onset breast cancer by immunohistochemistry. Furthermore, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Ret Proto-oncogene Mutation in Korean Patients with Medullary Thyroid Carcinomas

Kim HH, Kim HJ, Chung YJ, Min YK, Lee MS, Lee MK, Kim KW, Ki CS, Kim JW, Chung JH

  • KMID: 2200380
  • J Korean Soc Endocrinol.
  • 2003 Aug;18(4):360-370.
BACKGROUND: Medullary thyroid carcinomas (MTC) have been reported as hereditary in about 25 ~30% of cases. The identification of germline mutation in RET proto-oncogene is important in the diagnosis of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Multiple Endocrine Neoplasia Type 2B associated with a M918T Mutation in RET Proto-Oncogene

Kim TY, Hwang JK, Moon MK, Park YJ, Park DJ, Kim SY, Lee HK, Yoon YK, Cho BY

  • KMID: 2200144
  • J Korean Soc Endocrinol.
  • 2003 Feb;18(1):85-93.
A multiple endocrine neoplasia type 2B(MEN2B) is the most distinct and aggressive form of the MEN type 2 variants. We report a case of a 24-years-old woman with MEN2B. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HER-2/neu Oncogene Amplification by Chromogenic in situ Hybridization and Immunohistochemical Expression of Topoisomerase II-alpha in the Breast Cancer

Lee TJ, Oh HG, Kwon GY, Kim MK, Park ES, Yoo JH

  • KMID: 1725953
  • Korean J Pathol.
  • 2003 Feb;37(1):26-34.
BACKGROUND: Amplifications of the HER-2/neu oncogene and the Topoisomerase II-alpha gene are important determiners of the response to chemotherapy in the breast cancer. For detecting HER-2/neu amplification, fluorescent in situ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of C-MYC, C-RAS, C-ERB B-2 Oncogenes and P53 Gene in Hydatidiform Mole

Choi HS, Kim SM, Park CS

  • KMID: 1980217
  • Korean J Gynecol Oncol Colposc.
  • 2002 Dec;13(4):336-341.
OBJECTIVE: To date early predictors for the development of persistent gestational trophoblastic disease (PGTD) after evacuation of a complete hydatidiform mole were not known. The purpose of this study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change in Expression of Keratin and Proto-oncogene Induced by Beta-propiolactone in HaCaT Cell

Liu Y, Sung EG, Song IH, Du D, Kim DK, Park JH, Sung HK, Lee Y, Kim JY

  • KMID: 1559031
  • Korean J Anat.
  • 2001 Aug;34(4):389-404.
To investigate the relationship between the morphologic changes and the expression of keratin and proto-oncogene induced by Beta-propiolactone (BPL), we assessed on the expression of keratins (K8, K10, K13) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr